PAPER Crippa V, Carra S, Rusmini P, Sau D, Bolzoni E, Bendotti C, De Biasi S, Poletti A
SEARCH RESULTS
331254 RESULTS
PAPER Stefani M
Protein aggregation diseases: toxicity of soluble prefibrillar aggregates and their clinical significance.
Methods Mol Biol. 2010;648:25-41. PubMed: 20700703PAPER Bucciantini M, Cecchi C
Biological membranes as protein aggregation matrices and targets of amyloid toxicity.
Methods Mol Biol. 2010;648:231-43. PubMed: 20700716PAPER Zhou JY, Afjehi-Sadat L, Asress S, Duong DM, Cudkowicz M, Glass JD, Peng J
Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.
J Proteome Res. 2010 Oct 1;9(10):5133-41. PubMed: 20698585PAPER Andrasfalvy BK, Zemelman BV, Tang J, Vaziri A
Two-photon single-cell optogenetic control of neuronal activity by sculpted light.
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11981-6. PubMed: 20543137PAPER Sasaki S
Determination of altered mitochondria ultrastructure by electron microscopy.
Methods Mol Biol. 2010;648:279-90. PubMed: 20700720PAPER Canales JJ
Comparative neuroscience of stimulant-induced memory dysfunction: role for neurogenesis in the adult hippocampus.
Behav Pharmacol. 2010 Sep;21(5-6):379-93. PubMed: 20700045PAPER Fox A, Snollaerts T, Errecart Casanova C, Calciano A, Nogaj LA, Moffet DA
Selection for nonamyloidogenic mutants of islet amyloid polypeptide (IAPP) identifies an extended region for amyloidogenicity.
Biochemistry. 2010 Sep 14;49(36):7783-9. PubMed: 20698575PAPER Irwin N, Gault V, Flatt PR
Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?
Expert Opin Investig Drugs. 2010 Sep;19(9):1039-48. PubMed: 20698813PAPER do Carmo Carreiras M, Marco-Contelles J
The multifactorial nature of Alzheimer's disease and related therapeutic strategies.
Curr Pharm Des. 2010;16(25):2765. PubMed: 20698817PAPER Castro RE, Santos MM, Glória PM, Ribeiro CJ, Ferreira DM, Xavier JM, Moreira R, Rodrigues CM
Cell death targets and potential modulators in Alzheimer's disease.
Curr Pharm Des. 2010;16(25):2851-64. PubMed: 20698818PAPER Fernandez AP, Pozo-Rodrigalvarez A, Serrano J, Martinez-Murillo R
Nitric oxide: target for therapeutic strategies in Alzheimer's disease.
Curr Pharm Des. 2010;16(25):2837-50. PubMed: 20698819PAPER Agostinho P, Cunha RA, Oliveira C
Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Curr Pharm Des. 2010;16(25):2766-78. PubMed: 20698820PAPER Kawahara M
Neurotoxicity of β-amyloid protein: oligomerization, channel formation, and calcium dyshomeostasis.
Curr Pharm Des. 2010;16(25):2779-89. PubMed: 20698821PAPER Naoi M, Maruyama W
Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.
Curr Pharm Des. 2010;16(25):2799-817. PubMed: 20698822Current Filters
No filters selected